Potential rose for concurrent abnormalities of the cyclin D1, p16(CDKN2) and p15(CDKN2B) genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519)

Leukemia

Volumn 11, Issue 1, 1997, Pages 64-72

  Jadayel, D M ^a   Lukas, J ^b   Nacheva, E ^c   Bartkova, J ^b   Stranks, G ^a   De Schouwer, P J J C ^a   Lens, D ^a   Bartek, J ^b   Dyer, M J S ^a   Kruger, A R ^d   Catovsky, D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

Cell cycle; Cyclin D1; Mantle cell lymphoma; p15; p16

Indexed keywords

CYCLIN D1; MESSENGER RNA; PROTEIN P16; RETINOBLASTOMA PROTEIN; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLINE; ONCOPROTEIN; PROTEIN P16INK4A; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BREAST CANCER; CANCER GENETICS; CASE REPORT; CELL CYCLE G1 PHASE; CHROMOSOME 13P; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 9P; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; ELECTROPORATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOPRECIPITATION; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; CELL CULTURE; CHROMOSOME 11; CHROMOSOME 14; GENE DELETION; GENE TRANSLOCATION; GENETICS; KARYOTYPING; METABOLISM;

AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLINS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LYMPHOMA, B-CELL; NEOPLASM PROTEINS; ONCOGENE PROTEINS; RNA, MESSENGER; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030614550     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400555     Document Type: Article

References (14)

1. Rosenberg C, Wong E, Petty EM, Bale A, Tsujimoto Y, Harris N, Arnold A. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991; 88: 9638-9642.
2. Rimokh R, Berger F, Delsol G, Charrin C, Bertheas MF, French M, Garoscio M, Felman P, Coiffier C, Bryon PA, Rochet M, Gentillhomme O, Germain D, Magaugd JP. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993; 81: 3063-3067.
3. De Boer C, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, Van Krieken JH. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995; 86: 2715-1723.
4. Jadayel D, Matutes E, Dyer MJS, Brito-Babapulle V, Khokhar TM, Oscier D, Catovsky D. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene. Blood 1994; 83: 3664-3671.
5. Brito-Babapulle V, Ellis J, Matutes E, Oscier D, Khokhar T, MacLennan K, Catovsky D. Translocation t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chromosom Cancer 1992; 5: 158-165.
6. Sherr CJ. G1 phase progression: cycling on cues. Cell 1994; 79: 551-555.
7. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
8. Musgrove EA, Lee C, Buckley MF, Sutherland R. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 1994; 91: 8022-8026.
9. Bodrug S, Warner B, Bath M, Lindeman G, Harris A, Adams J. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphogenesis with the myc gene. EMBO J 1994; 13: 2124-2130.
10. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cellcycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-706.
11. INK4. Science 1995; 267: 249-252.
12. Merlo A, Herman J, Mao L, Lee D, Gabrielson E, Burger P, Baylin S, Sidransky D. 5′ CPG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-692.
13. Hirama T, Koeffler P. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995; 86: 841-854.
14. Stanks G, Height SE, Mitchell P, Jadayel D, Yuille M, De Lord C, Clutterbuck RD, Treleaven J, Powles R, Nacheva E, Oscier D, Karpas GM, Lenoir SD, Smith SD, Millar JL, Catovsky D, Dyer MJS. Deletion and rearrangement of CDKN2 in lymphoid malignancy. Blood 1995; 85: 893-901.